Prostate 3T-MR spectroscopic imaging without an endorectal surface coil using the MLEV-PRESS sequence

被引:1
作者
Yoshizako, Takeshi [1 ]
Uchida, Koji [1 ]
Hara, Shinji [1 ]
Kaji, Yasushi [2 ]
Sumura, Masahiro [3 ]
Igawa, Mikio [3 ]
Kitagaki, Hajime [1 ]
Uike, Mitsuhiro [4 ]
Matsuda, Tsuyoshi [4 ]
机构
[1] Shimane Univ, Dept Radiol, Fac Med, Izumo, Shimane, Japan
[2] Dokkyo Med Univ, Dept Radiol, Mibu, Tochigi, Japan
[3] Shimane Univ, Fac Med, Dept Urol, Izumo, Shimane, Japan
[4] GE Yokogawa Med Syst Ltd, GE Healthcare, Tokyo, Japan
关键词
Prostate; Volunteer; MR spectroscopic imaging; 3; Tesla; External array coil; PROTON MR SPECTROSCOPY; 3; TESLA; CANCER; LOCALIZATION; CITRATE;
D O I
10.1007/s11604-012-0165-5
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The aim of this study was to determine to what extent we could identify the metabolism product peak using 3-T proton magnetic resonance spectroscopic imaging (MRSI) of the prostate gland in healthy volunteers by combining an external array coil with Malcolm Levitt composite-pulse decoupling sequence (MLEV)-point-resolved spatially localized spectroscopy (PRESS). MRSI data were obtained from the entire prostate gland in six healthy volunteers. The heights of the choline, citrate peaks and the standard deviation (SD) of the noise in each voxel were calculated. When the choline and/or citrate peak in a voxel exceeded 3 SD, the peak was clearly identified. The clear citrate peak rate in the peripheral zone (PZ) and the central gland (CG) were 78.8 and 70.3 %, respectively. The clear choline peak rate in the PZ and the CG were 55.4 and 44.9 %, respectively. In addition, the clear peak rates for both citrate and choline in the PZ and the CG were 51.8 and 38.6 %. Therefore, in the entire prostate gland, 75.2 % had a clear citrate peak, 51.1 % had a clear choline peak, and 46.3 % had both citrate and choline peaks. The citrate peak was clearly detected in 75.2 % of the voxels by this technique.
引用
收藏
页码:220 / 225
页数:6
相关论文
共 18 条
[1]   SPATIAL LOCALIZATION IN NMR-SPECTROSCOPY INVIVO [J].
BOTTOMLEY, PA .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1987, 508 :333-348
[2]   Time-domain combination of MR spectroscopy data acquired using phased-array coils [J].
Brown, MA .
MAGNETIC RESONANCE IN MEDICINE, 2004, 52 (05) :1207-1213
[3]   CONCEPTS OF CITRATE PRODUCTION AND SECRETION BY PROSTATE .1. METABOLIC RELATIONSHIPS [J].
COSTELLO, LC ;
FRANKLIN, RB .
PROSTATE, 1991, 18 (01) :25-46
[4]   Sequence design for magnetic resonance spectroscopic imaging of prostate cancer at 3T [J].
Cunningham, CH ;
Vigneron, DB ;
Marjanska, M ;
Chen, AP ;
Xu, D ;
Hurd, RE ;
Kurhanewicz, J ;
Garwood, M ;
Pauly, JM .
MAGNETIC RESONANCE IN MEDICINE, 2005, 53 (05) :1033-1039
[5]  
Fütterer JJ, 2004, INVEST RADIOL, V39, P671
[6]  
Heerschap A, 1997, ANTICANCER RES, V17, P1455
[7]   Proton two-dimensional chemical shift imaging for evaluation of prostate cancer: External surface coil vs. endorectal surface coil [J].
Kaji, Y ;
Wada, A ;
Imaoka, I ;
Matsuo, M ;
Terachi, T ;
Kobashi, Y ;
Sugimura, K ;
Fujii, M ;
Maruyama, K ;
Takizawa, O .
JOURNAL OF MAGNETIC RESONANCE IMAGING, 2002, 16 (06) :697-706
[8]   Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.1-cm(3)) spatial resolution [J].
Kurhanewicz, J ;
Vigneron, DB ;
Hricak, H ;
Narayan, P ;
Carroll, P ;
Nelson, SJ .
RADIOLOGY, 1996, 198 (03) :795-805
[9]   CITRATE AS AN IN-VIVO MARKER TO DISCRIMINATE PROSTATE-CANCER FROM BENIGN PROSTATIC HYPERPLASIA AND NORMAL PROSTATE PERIPHERAL ZONE - DETECTION VIA LOCALIZED PROTON SPECTROSCOPY [J].
KURHANEWICZ, J ;
VIGNERON, DB ;
NELSON, SJ ;
HRICAK, H ;
MACDONALD, JM ;
KONETY, B ;
NARAYAN, P .
UROLOGY, 1995, 45 (03) :459-466
[10]   3D proton MR spectroscopic imaging of prostate cancer using a standard spine coil at 1.5 T in clinical routine: a feasibility study [J].
Lichy, MP ;
Pintaske, J ;
Kottke, R ;
Machann, J ;
Anastasiadis, A ;
Roell, S ;
Hennenlotter, J ;
Diergarten, T ;
Schick, F ;
Stenzl, A ;
Claussen, CD ;
Schlemmer, HP .
EUROPEAN RADIOLOGY, 2005, 15 (04) :653-660